Authors
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNewly developed acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Global partnership targets ROP in premature infantsAn AI-supported telemedicine effort from Siloam Vision and Orbis International
Latest:
New options are on the horizon for presbyopia-correcting dropsFor ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.
Latest:
Harnessing digital media for enhanced patient engagement and outcomesPatients who received digital education demonstrated a better understanding of their disease and its management
Latest:
Using pivotal study data to guide glaucoma patient management decisionsTwo randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Latest:
Digital visual training helps treat disorders associated with close workComputer software platform provides home vision exercises to overcome asthenopia.
Latest:
Zooming in on geographic atrophy with OCT-based AINew analysis brings disease progression and therapeutics into focus
Latest:
Six-year findings from laser in glaucoma and ocular hypertension (LiGHT)In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma
Latest:
Optimizing diagnosis and surgical management of diabetic retinopathy using advanced imaging technologiesDiabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.
Latest:
Letter to the Editor: Intravitreal injections. Who should perform them?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
Back to the cornea – Treating hyperopic patients with Lenticule ExtractionLenticule Extraction for treating patients with hyperopia is now available with SMILE® pro, performed on the VISUMAX® 800 from ZEISS. This additional option provides a valuable corneal-based alternative for younger patients without cataract. In this Case of the Month, you will discover the advantages of this procedure and review the outcomes of a 30-year-old patient who chose to undergo Lenticule Extraction with ZEISS SMILE pro after experiencing discomfort with contact lenses for many years.
Latest:
First-ever retinal gene therapy: Does real-world experience back its use?Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Latest:
Opthea discontinues COAST and ShORe sozinibercept combination therapy trialsBoth trials failed to meet their primary endpoints for treatment of age-related macular degeneration
Latest:
Focusing on functional vision with monofocal lensesQuantitative and qualitative improvement in IOL design
Latest:
Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye diseaseA short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.
Latest:
Cross-linking in paediatric patients: The case for treating keratoconus without waiting for disease progressionThe case for treating keratoconus without waiting for disease progression
Latest:
TEASE-3 study: Positive interim data are reported for Stargardt drugGildeuretinol halts Stargardt disease progression, study results indicate
Latest:
Distorted corneas: How to regularise them with minimally invasive surgerySequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations
Latest:
Gene therapy research ushers in new therapy options for retinal diseasesFoundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.
Latest:
Risks and management of diabetic retinopathy in paediatric patientsDiabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.
Latest:
The impact of landmark studies on clinical practice in glaucomaLandmark randomised controlled trials have advanced the understanding and treatment of glaucoma.
Latest:
Landscape of genetic therapies for USH2A-related retinitis pigmentosaIncreasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.
Latest:
Assessing barriers to retinal care during a pandemicA global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Latest:
The shifting landscape of conjunctival hyperemiaEuropean patients navigate new therapies and market change-ups
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
Latest:
Shining new light on ocular surface careLow-level light therapy for dry eye disease and chalazion
Latest:
Keratoconus: Intrastromal implantation of fresh human lenticulesStromal regeneration seems possible in patients with keratoconus.
